Literature DB >> 19644442

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

Anthony E Fiore1, David K Shay, Karen Broder, John K Iskander, Timothy M Uyeki, Gina Mootrey, Joseph S Bresee, Nancy J Cox.   

Abstract

This report updates the 2008 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and control of seasonal influenza (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2008;57[No. RR-7]). Information on vaccination issues related to the recently identified novel influenza A H1N1 virus will be published later in 2009. The 2009 seasonal influenza recommendations include new and updated information. Highlights of the 2009 recommendations include 1) a recommendation that annual vaccination be administered to all children aged 6 months-18 years for the 2009-10 influenza season; 2) a recommendation that vaccines containing the 2009-10 trivalent vaccine virus strains A/Brisbane/59/2007 (H1N1)-like, A/Brisbane/10/2007 (H3N2)-like, and B/Brisbane/60/2008-like antigens be used; and 3) a notice that recommendations for influenza diagnosis and antiviral use will be published before the start of the 2009-10 influenza season. Vaccination efforts should begin as soon as vaccine is available and continue through the influenza season. Approximately 83% of the United States population is specifically recommended for annual vaccination against seasonal influenza; however, <40% of the U.S. population received the 2008-09 influenza vaccine. These recommendations also include a summary of safety data for U.S. licensed influenza vaccines. These recommendations and other information are available at CDC's influenza website (http://www.cdc.gov/flu); any updates or supplements that might be required during the 2009-10 influenza season also can be found at this website. Vaccination and health-care providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19644442

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  242 in total

1.  Low influenza vaccination rates among child care workers in the United States: assessing knowledge, attitudes, and behaviors.

Authors:  Marie A de Perio; Douglas M Wiegand; Stefanie M Evans
Journal:  J Community Health       Date:  2012-04

2.  Vaccination of oncology patients: an effective tool and an opportunity not to be missed.

Authors:  Camille N Kotton; Mark C Poznansky
Journal:  Oncologist       Date:  2012-01-12

3.  Influenza vaccination: financial burden or public health solution?

Authors:  Marina V Zeltser
Journal:  Biotechnol Healthc       Date:  2009-10

4.  Cost comparison of 2 mass vaccination campaigns against influenza A H1N1 in New York City.

Authors:  Susan M Kansagra; Meghan D McGinty; Beth Maldin Morgenthau; Monica L Marquez; Annmarie Rosselli-Fraschilla; Jane R Zucker; Thomas A Farley
Journal:  Am J Public Health       Date:  2011-12-15       Impact factor: 9.308

Review 5.  Economic evaluations of childhood influenza vaccination: a critical review.

Authors:  Anthony T Newall; Mark Jit; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

6.  Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus.

Authors:  Jonathan A McCullers; Lee-Ann Van De Velde; Kim J Allison; Kristen C Branum; Richard J Webby; Patricia M Flynn
Journal:  Clin Infect Dis       Date:  2010-06-01       Impact factor: 9.079

Review 7.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

8.  Establishing the baseline burden of influenza in preparation for the evaluation of a countywide school-based influenza vaccination campaign.

Authors:  Carlos G Grijalva; Yuwei Zhu; Lone Simonsen; Marie R Griffin
Journal:  Vaccine       Date:  2010-11-02       Impact factor: 3.641

9.  The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines.

Authors:  Yuk-Fai Lau; Celia Santos; Fernando J Torres-Vélez; Kanta Subbarao
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

10.  Impact of the raising immunizations safely and effectively (RISE) program on healthcare worker influenza immunization rates in long term care settings.

Authors:  David A Nace; Steven M Handler; Erika L Hoffman; Subashan Perera
Journal:  J Am Med Dir Assoc       Date:  2012-09-30       Impact factor: 4.669

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.